DRKS00015034
Completed
未知
Evaluation of Hemostatics in coagulation inhibited human blood with viscoelastic testing (ROTEM) - HemPIC (Hemostatics in Patients with Inhibited Coagulation)
Bundeswehrkrankenhaus UlmKlinik für Anästhesie und IntensivmedizinSektion Notfallmedizin0 sites40 target enrollmentOctober 26, 2018
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- R58
- Sponsor
- Bundeswehrkrankenhaus UlmKlinik für Anästhesie und IntensivmedizinSektion Notfallmedizin
- Enrollment
- 40
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Control group:
- •\- Healthy, especially concerning coagulation
- •\- Informed consent
- •Intervention group:
- •\- Regular medication of one of the following medications: Phenprocoumon, Enoxaparin, acetylsalicylic acid and Ticagrelor (combination), Dabigatran, Apixaban
- •\- Informed consent
- •\- Heparin Group: surgery with a mandatory heparin application during surgery
Exclusion Criteria
- •Control group:
- •\- Bleeding disorders (e.g. haemophilia, factor 5 Leiden mutation)
- •\- Medications within the last 10 days
- •\- Regular medication
- •\- Missing informed consent
- •\- Malignancies of the haematopoietic system
- •\- Status after diseases which caused a stay at hospital or doctor’s consultation during the last 14 days
- •\- HES \> 1,5 l during the past 4 weeks
- •Intervention group:
- •\- Regular medication of more than one of the following: Phenprocoumon, Enoxaparin, acetylsalicylic acid and Ticagrelor, Dabigatran, Apixaban, acetylsalicylic acid
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Potential influence of coagulation inhibitionon the perception of fear or aggressivenessI48Atrial fibrillation and flutterDRKS00017043niversitätsklinik für Kardiologie und Angiologie25
Not yet recruiting
Phase 3
Investigating the effectiveness of anticoagulants compared to aspirin and clopidogrel on disease severity in patients with ischemic stroke.IRCT20221026056307N1Bojnourd University of Medical Sciences86
Completed
Not Applicable
Clinical evaluation on activation of coagulation and fibrinolytic system during major cardiovascular surgerymajor cardiovascular surgery with use of cardiopulmonary bypassJPRN-UMIN000010866Teikyo University Hospital60
Not yet recruiting
Not Applicable
Assessing the correlations of anticoagulant effects between Thromboelastography [TEG] and anti-Xa activity in patients on therapeutic dose of low-molecular-weight heparin (LMWH)?Acute coronary syndromeBlood - Other blood disordersACTRN12609000055202Hayden White60
Active, not recruiting
Phase 1
Substitution of coagulation factors and blood products in patients with liver cirrhosisiver cirrhosisMedDRA version: 20.0Level: LLTClassification code 10024667Term: Liver cirrhosisSystem Organ Class: 100000004871Therapeutic area: Diseases [C] - Digestive System Diseases [C06]EUCTR2021-006870-22-ATMedical University of Vienna400